Fresenius traded at 26.98 this Friday December 2nd, increasing 0.47 or 1.77 percent since the previous trading session. Looking back, over the last four weeks, Fresenius gained 19.91 percent. Over the last 12 months, its price fell by 19.34 percent. Looking ahead, we forecast Fresenius to be priced at 24.70 by the end of this quarter and at 21.91 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
26.98
Daily Change
1.77%
Yearly
-19.34%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Akzo Nobel 68.12 0.72 1.07% -28.98%
Alcon AG 65.60 0.12 0.18% -10.09%
AstraZeneca 11,190.00 -10.00 -0.09% 36.61%
BASF 48.60 0.74 1.55% -16.78%
Bayer 54.95 -0.08 -0.15% 24.17%
Beiersdorf 105.75 0.10 0.09% 20.31%
DSM 126.70 2.45 1.97% -33.42%
DaVita Healthcare Partners 74.34 1.11 1.52% -24.79%
Essilor 180.25 2.25 1.26% 1.84%
E.ON 9.20 0.11 1.21% -14.47%
Fresenius Medical Care 31.04 0.71 2.34% -42.43%
Fresenius Medical Care 16.38 0.40 2.50% -46.15%
Fresenius 26.98 0.47 1.77% -19.34%
Getinge 250.60 5.10 2.08% -33.14%
Givaudan 3,172.00 -12.00 -0.38% -30.36%
GN Store Nord 180.55 3.15 1.78% -49.72%
GRIFOLS 10.63 0.08 0.76% -30.82%
GlaxoSmithKline 1,425.20 9.80 0.69% -7.13%
Hikma Pharmaceutical 1,534.00 -7.50 -0.49% -30.18%
Lonza Group 503.80 -5.20 -1.02% -29.87%
Merck 176.95 0.40 0.23% -17.16%
Novartis 84.11 0.01 0.01% 14.33%
Philips 14.51 0.22 1.54% -51.94%
Roche Holding 309.15 -0.85 -0.27% -14.66%
RWE 41.99 -0.66 -1.55% 21.22%
Sanofi 85.84 -1.61 -1.84% 2.47%
Smith & Nephew PLC 1,090.50 12.00 1.11% -11.34%
William Demant Holding 206.40 0.20 0.10% -31.93%

Indexes Price Day Year
DE40 14529 39.09 0.27% -4.22%
EU50 3978 -6.60 -0.17% -2.51%

Fresenius
Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes in intravenously administered generic drugs (IV drugs), clinical nutrition and infusion therapies. It also supplies hospitals with medical devices and products of transfusion technology. Fresenius Helios is a private hospital operator, with over 130 facilities in Germany, including maximum care hospitals and rehabilitation centers and, through Quironsalud, over 80 hospitals and outpatient centers, as well as approximately 300 Occupational Risk Prevention Centers in Spain. Fresenius Vamed manages projects and provides services for health care facilities worldwide, from development and turnkey construction to maintenance and total operational management.